Condition: Hepatocellular Carcinoma · Intrahepatic Cholangiocarcinoma · Cholangiocarcinoma · Sponsor: City of Hope Medical Center
It is sometimes difficult to precisely understand whether a primary liver cancer is a hepatocellular carcinoma or a cholangiocarcinoma. The researchers will develop and validate a liquid biopsy, based on exosomal content analysis and powered by machine learning, to help clinicians differentiate these two cancers before surgery.
This description comes directly from the study's public registry record.
Ajay Goel, PhD · 6262183452 · AJGOEL@COH.ORG
Always discuss trial participation with your own doctor first.
| City of Hope Medical Center | Duarte, California, United States | Recruiting |
| Graduate School of Medical Sciences, Kyushu University | Fukuoka, Japan | Recruiting |
| Graduate School of Medical Sciences, Kumamoto University | Kumamoto, Japan | Recruiting |
| Hokkaido University Graduate School of Medicine | Sapporo, Japan | Recruiting |
| Tokushima University | Tokushima, Japan | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06342414